DE60213827D1 - Antikörper gegen Caspase-8, ihre Herstellung und Verwendung - Google Patents

Antikörper gegen Caspase-8, ihre Herstellung und Verwendung

Info

Publication number
DE60213827D1
DE60213827D1 DE60213827T DE60213827T DE60213827D1 DE 60213827 D1 DE60213827 D1 DE 60213827D1 DE 60213827 T DE60213827 T DE 60213827T DE 60213827 T DE60213827 T DE 60213827T DE 60213827 D1 DE60213827 D1 DE 60213827D1
Authority
DE
Germany
Prior art keywords
caspase
antibodies
production
relates
specific region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60213827T
Other languages
English (en)
Other versions
DE60213827T2 (de
Inventor
David Wallach
Tanya Goncharov
Ganesh Kolumam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of DE60213827D1 publication Critical patent/DE60213827D1/de
Application granted granted Critical
Publication of DE60213827T2 publication Critical patent/DE60213827T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60213827T 2001-09-04 2002-09-04 Antikörper gegen Caspase-8, ihre Herstellung und Verwendung Expired - Fee Related DE60213827T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL14527901 2001-09-04
IL14527901A IL145279A0 (en) 2001-09-04 2001-09-04 Antibodies against caspase-8, their preparation and use
PCT/IL2002/000734 WO2003020767A2 (en) 2001-09-04 2002-09-04 Antibodies against caspase-8, their preparation and use

Publications (2)

Publication Number Publication Date
DE60213827D1 true DE60213827D1 (de) 2006-09-21
DE60213827T2 DE60213827T2 (de) 2007-03-29

Family

ID=11075764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60213827T Expired - Fee Related DE60213827T2 (de) 2001-09-04 2002-09-04 Antikörper gegen Caspase-8, ihre Herstellung und Verwendung

Country Status (18)

Country Link
US (2) US20050058648A1 (de)
EP (2) EP1770101A1 (de)
JP (1) JP2005501905A (de)
KR (1) KR20040044535A (de)
CN (1) CN1599755A (de)
AT (1) ATE335766T1 (de)
BR (1) BR0212289A (de)
CA (1) CA2458985A1 (de)
CY (1) CY1106200T1 (de)
DE (1) DE60213827T2 (de)
DK (1) DK1423429T3 (de)
EA (1) EA009770B1 (de)
ES (1) ES2265511T3 (de)
IL (1) IL145279A0 (de)
MX (1) MXPA04002104A (de)
PT (1) PT1423429E (de)
UA (1) UA78526C2 (de)
WO (1) WO2003020767A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
US7838645B2 (en) * 2004-04-30 2010-11-23 University Of Maryland College Park Function of autophagy genes in cell death
KR101278690B1 (ko) * 2009-10-19 2013-06-24 한올바이오파마주식회사 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법
CN106146665B (zh) * 2016-08-31 2019-08-09 中国农业科学院植物保护研究所 一种用于制备针对甜菜夜蛾caspase-5大亚基的抗体的方法
CN112255061A (zh) * 2020-10-13 2021-01-22 南开大学 一种通过免疫沉淀分离和检测蛋白质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
WO2000077201A1 (en) * 1999-06-15 2000-12-21 Astrazeneca Ab Livin; inhibitor-of-apoptosis protein-3 (iap-3)
FR2878852B1 (fr) * 2000-09-28 2007-02-23 Imtix Sangstat Procede de production d'immunoglobulines anti-thymocytes humains

Also Published As

Publication number Publication date
MXPA04002104A (es) 2004-06-07
WO2003020767A2 (en) 2003-03-13
US20050058648A1 (en) 2005-03-17
BR0212289A (pt) 2004-09-14
CA2458985A1 (en) 2003-03-13
IL145279A0 (en) 2002-06-30
EA009770B1 (ru) 2008-04-28
WO2003020767A3 (en) 2003-10-02
EP1770101A1 (de) 2007-04-04
EP1423429B1 (de) 2006-08-09
CY1106200T1 (el) 2011-06-08
JP2005501905A (ja) 2005-01-20
DE60213827T2 (de) 2007-03-29
ATE335766T1 (de) 2006-09-15
WO2003020767A9 (en) 2004-04-15
EA200400393A1 (ru) 2004-08-26
DK1423429T3 (da) 2006-09-04
UA78526C2 (en) 2007-04-10
KR20040044535A (ko) 2004-05-28
EP1423429A2 (de) 2004-06-02
ES2265511T3 (es) 2007-02-16
PT1423429E (pt) 2006-12-29
US20080311599A1 (en) 2008-12-18
CN1599755A (zh) 2005-03-23

Similar Documents

Publication Publication Date Title
ATE539062T1 (de) Bizyklishe verbindung, ihre herstellung und verwendung
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
ATE319684T1 (de) Sulfonamidderivate, deren herstellung und deren verwendung als medikamente
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
DE60204349D1 (de) 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung
DE10084441T1 (de) Koalinton-Pigmente, ihre Herstellung und Verwendung
DE60038200D1 (de) ren Herstellung und Verwendung
DE60235547D1 (de) En daraus, deren herstellung und verwendung
ATE316966T1 (de) Benzoxazinonderivate, deren herstellung und deren verwendung als medikamente
ATE302604T1 (de) Thienylazolylalkoxyethanamine, deren herstellung und deren verwendung als medikamente
DE60200427D1 (de) Vernetzbare Fluorelastomerzusammensetzungen, ihre Herstellung und Verwendung
ATE265454T1 (de) Phenyloxazol-1,4-diazabicyclo(3.2.2)nonanderiva e,ihre herstellung und ihre therapeutische verwendung
DE60103394D1 (de) 4-(2-phenylthiazol-5-yl)1,4-diazabicyclo[3.2.2]nonanederivate, ihre herstellung und therapeutische verwendung
ATE533768T1 (de) Imidazol-derivate, ihre herstellung und ihre verwendung
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
ATE305927T1 (de) Perfluoralkylamide, ihre herstellung und ihre verwendung in der diagnostik
ATE505459T1 (de) Dibenzoäb,füazepin-derivate und ihre herstellung
ATE483714T1 (de) Podophyllotoxine als antiproliferative mittel
ATE335766T1 (de) Antikörper gegen caspase-8, ihre herstellung und verwendung
ATE484503T1 (de) 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva
ATE339474T1 (de) 1:2 metallkomplexfarbstoffe, deren zusammensetzungen, deren herstellung und deren verwendung
ATE451366T1 (de) Sulphonamid benzoxazinonderivate. ihre herstellung und verwendung als medikamente
ATA20102001A (de) Uv-resistenter, thermohärtbarer aminoplastverbund, dessen herstellung und verwendung
DZ3441A1 (fr) Nouvelles phenylpiperazines.
ATE557012T1 (de) Substituierte 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-one sowie ihre herstellung und verwendung in arzneistoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee